Summary
This 2021 focused update to the Japanese Circulation Society and Japanese Heart Failure Society guidelines synthesises current evidence on the diagnosis and treatment of both acute and chronic heart failure. As a professional consensus document, it represents the collective assessment of cardiovascular specialists regarding optimal clinical management strategies and diagnostic approaches in the Japanese healthcare context. The guideline likely incorporates recent pharmacological, device-based, and lifestyle interventions relevant to heart failure care.
UK applicability
Whilst this is a Japan-specific guideline, the underlying cardiovascular physiology and many therapeutic principles are universally applicable; however, UK clinicians would primarily reference NICE or ESC guidelines adapted for National Health Service practice and drug formularies. Japanese-specific epidemiological data or health system considerations may have limited direct applicability to UK settings.
Key measures
Diagnostic criteria, therapeutic interventions, clinical outcomes, and evidence-based recommendations for heart failure management
Outcomes reported
The guideline provides updated recommendations on the diagnosis and management of acute and chronic heart failure based on current evidence and expert consensus.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.